CareDx Advances Patient Care with AlloSure 3.0
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: GlobeNewswire
BRISBANE, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announces the launch of AlloSure 3.0, the next iteration in continued transplant patient-focused improvements. CareDx continues to drive innovation in the field. AlloSure continues to provide: Better care with a new minimum of only one tube of blood requiredBetter science with the lowest limit of detection now at 0.12%Better insights by appropriately stratifying patients with T-cell mediated rejection (TCMR) CareDx has new data showing AlloSure provides more in-depth insights into patients with TCMR1A and borderline rejection. Data suggests the heterogeneous pattern of these diagnoses is associated with varying degrees of organ injury. The prospective, multicenter analysis across leading transplant center
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- Are Medical Stocks Lagging CareDx (CDNA) This Year? [Yahoo! Finance]Yahoo! Finance
- CareDx to Participate in Upcoming Investor ConferencesBusiness Wire
- Accelerated Testing Volume Lifted CareDx (CDNA) in Q3 [Yahoo! Finance]Yahoo! Finance
- CareDx Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- CareDx, Inc (NASDAQ: CDNA) had its price target lowered by analysts at BTIG Research from $40.00 to $35.00. They now have a "buy" rating on the stock.MarketBeat
CDNA
Earnings
- 11/4/24 - Beat
CDNA
Sec Filings
- 11/14/24 - Form SC
- 11/8/24 - Form 4
- 11/8/24 - Form SC
- CDNA's page on the SEC website